Jing J. Wang
Immunology and Microbiology · The Ohio State University
Publications
43
Citations
60
Est. group size
~2
Recurring co-author estimate
Active years
6
Publishing since 2021
Jing J. Wang's research focuses on the molecular biology of cancer, particularly how loss of the VHL gene (a tumor suppressor often lost in kidney cancer) drives tumor growth through specific proteins and signaling pathways. Work includes genome-wide screening to identify new cancer-driving genes and the discovery of compounds that selectively kill tumor cells by disrupting microtubules (structural components cells need to divide). The research connects immune signaling, protein degradation pathways, and cancer mechanisms.
Publication output was minimal or absent from 2017-2022 but increased sharply starting in 2023, suggesting a recent surge in research activity.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- 90P Discovery of CMPD1 as a tumor-specific cytotoxic microtubule inhibitor
Annals of Oncology · 2023
- Genome-wide Screening Identifies SFMBT1 as an Oncogenic Driver in Cancer with VHL Loss
UNC Libraries · 2022
- VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma
UNC Libraries · 2021
- UNC Libraries×2
- Frontiers in Oncology×1
- Cancer Letters×1
- Molecular Cancer Therapeutics×1
- Clinical Cancer Research×1
- Xuanxuan Xing
Immunology and Microbiology · The Ohio State University
- Evan H. Zhang
Immunology and Microbiology · The Ohio State University
- Xinru Zheng
Immunology and Microbiology · The Ohio State University
- Wayne Miles
Immunology and Microbiology · The Ohio State University
- Beiyuan Liang
Immunology and Microbiology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile